Metformin Hydrochloride; Saxagliptin Hydrochloride Patent Expiration
Metformin Hydrochloride; Saxagliptin Hydrochloride is Used for improving glycemic control in adults with type 2 diabetes mellitus. It was first introduced by Astrazeneca Ab
Metformin Hydrochloride; Saxagliptin Hydrochloride Patents
Given below is the list of patents protecting Metformin Hydrochloride; Saxagliptin Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Kombiglyze Xr | US8628799 | Coated tablet formulation and method | Jul 13, 2025 | Astrazeneca Ab |
| Kombiglyze Xr | US9339472 | Coated tablet formulation and method | Jul 13, 2025 | Astrazeneca Ab |
| Kombiglyze Xr | USRE44186 | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
Jul 31, 2023
(Expired) | Astrazeneca Ab |
| Kombiglyze Xr | US6395767 | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
Feb 16, 2021
(Expired) | Astrazeneca Ab |
Metformin Hydrochloride; Saxagliptin Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Metformin Hydrochloride; Saxagliptin Hydrochloride Generics
Several generic applications have been filed for Metformin Hydrochloride; Saxagliptin Hydrochloride. The first generic version for Metformin Hydrochloride; Saxagliptin Hydrochloride was by Mylan Pharmaceuticals Inc and was approved on Jul 31, 2023. And the latest generic version is by Dr Reddys Laboratories Sa and was approved on Aug 9, 2023.
Given below is the list of companies who have filed for Metformin Hydrochloride; Saxagliptin Hydrochloride generic.
1. DR REDDYS LABS SA
Dr Reddys Laboratories Sa has filed for 3 different strengths of generic version for Metformin Hydrochloride; Saxagliptin Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Sa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG; EQ 5MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 9, 2023 |
| 1GM; EQ 2.5MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 9, 2023 |
| 1GM; EQ 5MG BASE
(reference standard) | tablet, extended release | Prescription | ORAL | AB | Aug 9, 2023 |
2. MYLAN
Mylan Pharmaceuticals Inc has filed for 3 different strengths of generic version for Metformin Hydrochloride; Saxagliptin Hydrochloride. All of these versions come by the name SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG; EQ 5MG BASE | tablet, extended release | Prescription | ORAL | AB | Jul 31, 2023 |
| 1GM; EQ 2.5MG BASE | tablet, extended release | Prescription | ORAL | AB | Jul 31, 2023 |
| 1GM; EQ 5MG BASE | tablet, extended release | Prescription | ORAL | AB | Jul 31, 2023 |
3. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Metformin Hydrochloride; Saxagliptin Hydrochloride. All of these versions come by the name SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG; EQ 5MG BASE | tablet, extended release | Prescription | ORAL | AB | Jul 31, 2023 |
| 1GM; EQ 2.5MG BASE | tablet, extended release | Prescription | ORAL | AB | Jul 31, 2023 |
| 1GM; EQ 5MG BASE | tablet, extended release | Prescription | ORAL | AB | Jul 31, 2023 |